The Food and Drug Administration has approved the Carotid Wallstent Monorail Endoprosthesis for treatment of patients with carotid artery disease who are at high risk of surgery. The stent's closed-cell design is engineered for optimal lesion coverage. It is the leading carotid artery stent in Europe and other international markets. For more information, contact Boston Scientific Corp. by visiting www.bostonscientific.com